EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a Ferritin Protein Nanoparticle Vaccine with PRRSV GP5 Protein

Xinjian Chang, Jun Ma, Yanrong Zhou iD, Shaobo Xiao iD, Xun Xiao, Liurong Fang iD

Viruses · 20.06.2024 · 16 (6) · 991

DOI: 10.3390/v16060991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, online erschienen am 20.06.2024. Verfasst von Xinjian Chang und 5 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China. Hauptthemen laut MEDLINE: Porcine respiratory and reproductive syndrome virus, Ferritins, Mice, Inbred BALB C, Antibodies, Viral. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Porcine reproductive and respiratory syndrome virus (PRRSV) presents a significant threat to the global swine industry. The development of highly effective subunit nanovaccines is a promising strategy for preventing PRRSV variant infections. In this study, two different types of ferritin (Ft) nanovaccines targeting the major glycoprotein GP5, named GP5m-Ft and (Bp-IVp)3-Ft, were constructed and evaluated as vaccine candidates for PRRSV. Transmission electron microscopy (TEM) and dynamic light scattering (DLS) demonstrated that both purified GP5m-Ft and (Bp-IVp)3-Ft proteins could self-assemble into nanospheres. A comparison of the immunogenicity of GP5m-Ft and (Bp-IVp)3-Ft with an inactivated PRRSV vaccine in BALB/c mice revealed that mice immunized with GP5m-Ft exhibited the highest ELISA antibody levels, neutralizing antibody titers, the lymphocyte proliferation index, and IFN-γ levels. Furthermore, vaccination with the GP5m-Ft nanoparticle effectively protected piglets against a highly pathogenic PRRSV challenge. These findings suggest that GP5m-Ft is a promising vaccine candidate for controlling PRRS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Porcine respiratory and reproductive syndrome virusFerritinsMice, Inbred BALB CAntibodies, ViralAntibodies, NeutralizingNanoparticlesPorcine Reproductive and Respiratory SyndromeViral VaccinesViral Envelope ProteinsAnimalsSwineMiceFemaleInterferon-gammaNanovaccines

Stichwörter der Autor:innen

PRRSVferritinsubunit vaccinevirus-like particle

Substanzen

FerritinsAntibodies, ViralAntibodies, NeutralizingViral VaccinesViral Envelope Proteinsglycoprotein 5, PRRSVInterferon-gammaNanovaccines

Autor:innen und Institutionen

  • National Key Laboratory of Agricultural Microbiology, College of Veterinary Medicine, Huazhong Agricultural University, Wuhan 430070, China.
  • The Key Laboratory of Preventive Veterinary Medicine in Hubei Province, Cooperative Innovation Center for Sustainable Pig Production, Wuhan 430070, China.

ORCID-Profile: Yanrong Zhou, Shaobo Xiao, Liurong Fang

Förderung

  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Chang, X., Ma, J., Zhou, Y., Xiao, S., Xiao, X., & Fang, L. (2024). Development of a Ferritin Protein Nanoparticle Vaccine with PRRSV GP5 Protein. Viruses, 16(6), 991. https://doi.org/10.3390/v16060991

Vancouver

Chang X, Ma J, Zhou Y, Xiao S, Xiao X, Fang L. Development of a Ferritin Protein Nanoparticle Vaccine with PRRSV GP5 Protein. Viruses. 2024;16(6):991. doi:10.3390/v16060991

BibTeX
@article{Chang2024,
  author = {Chang, Xinjian and Ma, Jun and Zhou, Yanrong and Xiao, Shaobo and Xiao, Xun and Fang, Liurong},
  title = {Development of a Ferritin Protein Nanoparticle Vaccine with PRRSV GP5 Protein},
  journal = {Viruses},
  year = {2024},
  volume = {16},
  number = {6},
  pages = {991},
  doi = {10.3390/v16060991}
}
Kostenlos starten →